SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-023890
Filing Date
2020-11-16
Accepted
2020-11-16 08:00:35
Documents
52
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cbli20200930_10q.htm 10-Q 919238
2 EXHIBIT 10.2 ex_207860.htm EX-10.2 41802
3 EXHIBIT 10.3 ex_207859.htm EX-10.3 345042
4 EXHIBIT 31.1 ex_200079.htm EX-31.1 13737
5 EXHIBIT 32.1 ex_200080.htm EX-32.1 7518
  Complete submission text file 0001437749-20-023890.txt   4416582

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cbli-20200930.xml EX-101.INS 781342
7 XBRL TAXONOMY EXTENSION SCHEMA cbli-20200930.xsd EX-101.SCH 40269
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbli-20200930_cal.xml EX-101.CAL 29728
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbli-20200930_def.xml EX-101.DEF 262693
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbli-20200930_lab.xml EX-101.LAB 254217
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbli-20200930_pre.xml EX-101.PRE 285326
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32954 | Film No.: 201313738
SIC: 8731 Services-Commercial Physical & Biological Research